期刊文献+

琥珀酸索利那新联合吲哚美辛栓剂治疗女性膀胱过度活动症临床效果观察 被引量:4

Clinical effect observation of solifenacin succinate combined with indometacin suppositories in treatment of female patients with overactive bladder
下载PDF
导出
摘要 目的探讨琥珀酸索利那新联合吲哚美辛栓剂治疗女性膀胱过度活动症(OAB)的临床效果。方法选取2013年1月至2016年8月我院收治的OAB女性患者120例,随机分为两组。A组(60例)给予琥珀酸索利那新5mg/d,给予肛门塞吲哚美辛栓剂100mg,qn;B组(60例)给予琥珀酸索利那新5mg/d。治疗2周,观察用药前后24h平均排尿次数、24h平均尿失禁次数、24h平均单次尿量、尿急评分及膀胱过度活动症症状评分的变化。结果 A组24h平均排尿次数、24h平均尿失禁次数、尿急评分及膀胱过度活动症症状评分均低于B组,A组24h平均单次尿量高于B组,差异均有统计学意义(P<0.05)。两组患者均能耐受,但有10例出现药物不良反应,主要为轻度抗胆碱能作用,其中口干、眼干4例,视物模糊3例,消化不良3例。结论琥珀酸索利那新联合吲哚美辛栓剂可有效改善女性膀胱过度活动症的临床症状,提高生活质量,值得推广。 Objective To observe the clinical effect of solifenacin succinate combined with indometacin suppositories in treatment of female patients with overactive bladder.Methods A total of 120 cases OAB patients in our hospital from January 2013 to August 2016 were randomly divided into two groups:group A,group B(n=60,each).Patients in group A were given solifenacin succinate 5 mg/d and indometacin suppositories 100 mg,qn,in anus.Patients in group B were given solifenacin succinate 5mg/d.The period of treatement was 2 weeks.The difference before and after medication in the average micturition number of 24 hurination,the average urinary incontinence number of 24 hurination,the average single urine output of 24 hurination,urgency score and overactive bladder symptom score were observed.Results In group A,both the average micturition number of 24 hurination,the average urinary incontinence number of 24 hurination,urgency score and overactive bladder symptom score were shorter than group B.The average single urine output of 24 hurination in group A was higher than group B.There was significant difference between group A and group B(P<0.05).Patients in group A and group B could tolerate the treatment.But there were adverse reactions in 10 cases.The main manifestation of adverse reactions was slightly anticholinergic action including dry mouth and dry eye in 4 cases,blurred vision in 3 cases,and dyspepsia in 3 cases.Conclusion Solifenacin succinate combined with indometacin suppositories can effectively improve the clinical symptoms and the quality of life in female patients with OAB.It is worth wide application in clinical practice.
作者 罗波
出处 《青岛医药卫生》 2017年第5期337-339,共3页 Qingdao Medical Journal
关键词 索利那新 吲哚美辛栓 膀胱过度活动症 治疗 Solifenacin Indometacin suppositories Overactive bladder Therapy
  • 相关文献

参考文献3

二级参考文献32

  • 1杨尚琪,来永庆,陈月英,池泽湃,任瑞,王亚东,魏灿,倪梁朝,关志忱.膀胱过度活动症症状评分表评估膀胱过度活动症的临床研究[J].中华临床医师杂志(电子版),2012,6(16):4675-4678. 被引量:25
  • 2杨圣宇.中西医结合治疗幽门螺杆菌相关性慢性胃炎38例总结[J].湖南中医杂志,2005,21(1):12-13. 被引量:7
  • 3Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function, report from the standardisaton subcommittee of the International Continence Society. Neurourol Urodyn, 2002, 21: 167-178.
  • 4Rovner ES, Wein AJ. Incidence and prevalence of overactive bladder. Curr Urol Rep, 2002, 3:434- 438.
  • 5Irwin DE, Milsom I, Kopp Z, et al. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int, 2006, 97: 96-100.
  • 6Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int, 2007, 100: 987-1006.
  • 7Ikeda K, Kobayashi S, Suzuki M, et al. M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. N-S Arch Pharmacol, 2002, 366: 97-103.
  • 8Ohtake A, Ukai M, Hatanaka T, et al. In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats. Eur J Pharmaeol, 2004, 492:243- 250.
  • 9Kobayashi S, Ikeda K, Miyata K. Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells. Life Sci, 2004, 74: 843-853.
  • 10Smulders RA, Krauwinkel WJ, Swart PJ, et al. Pharmacokinetics and safety of solifenacin succinate in healthy young men. J Clin Pharmacol, 2004, 44:1023- 1033.

共引文献76

同被引文献62

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部